Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcitriol versus cinacalcet for hyperparathyroidism in hemodialysis patients
IRCT20190702044076N1Phase 3Completed
- Sponsor
- Shahrekord University of Medical Sciences
- Start
- Jul 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in hyperparathyroidism comparing Cinacalcet with Calcitriol (2 arms). Primary endpoints: Serum calcium, Serum phosphate and 1 more. Started Jul 2018; status: completed.
02
Drugs
cinacalcetcalcitriol
03
Conditions
hyperparathyroidism
Beyond the preview
Go deeper on IRCT20190702044076N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190702044076N1.